US Drug Recall Register
Class II · Moderate risk Terminated Initiated Jan 30, 2013 (14 years ago)

Lansoprazole Delayed-release Capsules, USP, 30 mg, 500-count capsules per bottle, Rx…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Presence of Foreign Tablets/Capsules: Bottles of lansoprazole 30 mg delayed-release capsules may contain topiramate 100 mg tablets.

What was recalled

Lansoprazole Delayed-release Capsules, USP, 30 mg, 500-count capsules per bottle, Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 U.S.A., Made in India, NDC 0378-8030-05.

Recalling firm
Mylan Pharmaceuticals Inc.
NDC code
0378-8030-05
Origin
WV, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-147-2013

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Lansoprazole recalls

See all